Navigation Links
Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs
Date:8/28/2007

- Plan Extends Financial Resources Beyond 2008 -

SOUTH SAN FRANCISCO, Calif., Aug. 28 /PRNewswire-FirstCall/ -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced that it is reducing its workforce by approximately 25 percent, and implementing a revised operating plan that focuses its efforts on generating definitive data from its lead programs while streamlining the company's operations and extending its financial resources beyond 2008.

Based on a rigorous assessment of its product portfolio, Sunesis' top priority is the advancement of its lead product candidate, SNS-595, for the treatment of acute myeloid leukemia (AML). Having seen clinical activity and a favorable therapeutic profile in its ongoing Phase 1 single-agent clinical trial of SNS-595, Sunesis is working closely with its clinical and regulatory advisors to design a registration trial for the treatment of elderly AML patients which it plans to initiate by the end of 2008. Additionally, Sunesis will soon begin dosing patients in a Phase 1b clinical trial of relapsed AML patients, combining SNS-595 with cytarabine, the leading treatment standard.

In addition to its development activities in AML, over the next eighteen months Sunesis expects to continue to advance its ongoing studies of SNS-595 in ovarian cancer, SNS-032 in B-cell malignancies and SNS-314 in solid tumors.

Positive data from any of these studies could support registration strategies or one or more significant development-stage collaborations. Sunesis' refocused research team will continue to generate insights on the chemistry and biology of the company's product candidates that may inform and guide clinical trials, to advance novel, small molecule i
'/>"/>

SOURCE Sunesis Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Deltanoid Pharmaceuticals begins phase II osteoporosis study
2. The Coming of Biotech Generic Pharmaceuticals
3. Speaker announces business members of IT Task Force
4. Doyle announces technology tax credits for Berbee
5. Doyle announces new energy, global warming policies
6. Doyle announces $80M renewable energy strategy
7. GE announces first installation of Discovery VCT
8. UWM announces winners of RGI awards
9. Third Wave announces two senior management appointments
10. Mirus announces new method for making antibodies
11. Merge announces sofware updates, upcoming acquisition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... 2013 Oven Industries Inc. announces a ... temperature controller has many user-friendly benefits. Contained all in ... wall as a self-contained temperature control system, ... makes the device unique, as well as highly convenient ... be used universally, which allows the user to use ...
(Date:5/17/2013)... Cardiff, UK (PRWEB) May 17, 2013 ... by Photonics21 at the association’s recent annual ... others including EC Vice-President Neelie Kroes, who called the ... between sectors, and a stimulant to European innovation.” , ... the structure of the new Photonics PPP at its ...
(Date:5/17/2013)... 2013  Yongye International, Inc. (NASDAQ: YONG ... and distributor of crop nutrient products in ... that, on May 16, 2013, the special committee (the ... of Directors") was provided a letter (the "Letter") issued ... ) Limited ("Abax") to Full Alliance International Limited ("Full ...
(Date:5/17/2013)... 2013 The paradigm of ‘one drug, ... that can help predict the adverse and therapeutic effects ... Head of Computational Biology at the Genomics Laboratory, Covance, ... ensure high-quality genomics when used as part of the ... complex data sets to identify key clinical targets even ...
Breaking Biology Technology:New Temperature Control Products Announced by Oven Industries Inc. 2SPIE Joins in Praise for ‘Huge Step Forward’ for Innovation R&D Enabled by Photonics21 Actions 2SPIE Joins in Praise for ‘Huge Step Forward’ for Innovation R&D Enabled by Photonics21 Actions 3Yongye International Provides Update on Status of Proposed Go Private Offer 2Yongye International Provides Update on Status of Proposed Go Private Offer 3Yongye International Provides Update on Status of Proposed Go Private Offer 4
... ALTO, Calif., July 22 CV Therapeutics,Inc. (Nasdaq: ... quarter,financial results for 2008 after the market closes on ... call at 5:00 p.m. EDT,2:00 p.m. PDT, on the ... log on to the Company,s website at, http://www.cvt.com ...
... The Board of,Directors of BD (Becton, Dickinson and ... of 28.5 cents per common share. The dividend will ... on September 9, 2008.,The indicated annual dividend rate is ... a leading global medical technology company that develops,manufactures and ...
... a Rochester, NY company today announced it is bringing aboard Ashton ... to head up global sales and marketing. , ... ... company today announced it is bringing aboard Ashton S. Maaraba, a ...
Cached Biology Technology:CV Therapeutics to Announce 2008 Second Quarter Financial Results on Thursday, July 31, 2008 2Pharmasmart International Taps Top Executive Ashton Maaraba to Head Global Sales and Marketing 2
(Date:5/17/2013)... An international team of scientists ... and cell movement inside a living frog embryo in ... new method to advance biological research and the search ... University and the Karlsruher Institut fr Technologie in Germany, ... U.S. Department of Energy,s Argonne National Laboratory, released the ...
(Date:5/16/2013)... Bethesda, MD FASEB MARC (Maximizing Access to ... recipients for The Endocrine Society (ENDO) 95th Annual ... 2013. These awards are meant to promote the ... groups into the mainstream of the basic science ... scientists at the ENDO 2013 Annual Meeting. , ...
(Date:5/16/2013)... closer to a fast food restaurant had a higher ... away from fast food, according to researchers at The ... association was particularly strong among those with a lower ... the American Journal of Public Health indicates ... food restaurant, and among lower-income African-Americans, the density, or ...
Breaking Biology News(10 mins):New X-ray method shows how frog embryos could help thwart disease 2Body mass index of low income African-Americans linked to proximity of fast food restaurants 2Body mass index of low income African-Americans linked to proximity of fast food restaurants 3
... software developments are helping farmers put the precision back ... to use previously ineffectual soil and environmental data to ... and producers, as well as lack of capacity to ... data languishing on hard drives rather than being used ...
... according to results of a new technique reported in ... National Academy of Sciences by researchers from Lawrence Livermore ... The researchers created a molecular clock by looking ... virus collected in 47 locations around the world, from ...
... for sensing the magnetic reference direction, have recently been ... al., PNAS, 2004). Furthermore, studies investigating what parts of ... use their magnetic compass showed that the cryptochrome-containing neurons ... Mouritsen et al., PNAS, 2005; Liedvogel et al., EJN, ...
Cached Biology News:Emphasizing the 'precision' in precision agriculture 2New molecular clock from LLNL and CDC indicates smallpox evolved earlier than believed 2New molecular clock from LLNL and CDC indicates smallpox evolved earlier than believed 3
...
... Johnstone and M.W. Turner (1997). • ... methods used in the production of ... in immunoassays, the standardisation of antibodies ... including amplification systems, enzyme immunoassays for ...
... PAGE Cleavable ICAT Reagent ... Protein ID and Quantitation ... Electrophoresis (PAGE), isotope-coded affinity ... technology to facilitate the ...
Thermal Printer Paper for Monolight(tm) Luminometer 1 each...
Biology Products: